Manufacturer record
SPM Drugs (P) Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by SPM Drugs (P) Ltd (Tamil Nadu) were declared Not of Standard Quality between January 2022 and May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 45PSA138, Phenytoin Sodium Injection USP-2ml (exp Apr 2026). King Institute of Preventive Medicine & Research, Guindy, Chennai-32 (state lab) found it not of standard quality: Sample does not conform to the requirement for assay. Listed in the May 2025 alert.
Records by type
2 records linked to SPM Drugs (P) Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Phenytoin Sodium Injection USP-2ml | Batch 45PSA138Mfg May 2024 · Exp Apr 2026 | Sample does not conform to the requirement for assayAssay | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab | May 2025 |
| Adrenochrome Monosemicarbazone Injection, 2 ml | Batch 01ACA295Mfg Feb 2021 · Exp Jul 2022 | Description & Particulate MatterDescription | CDL KolkataCDSCO lab | Jan 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.